Viewing nowPosiro Tablet 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 202200432 · Approved 2022.01.26 · Insurance code 054801380,641607910
Improvement of glycemic control in type 2 diabetes mellitus; chronic heart failure; inhibition of worsening of chronic kidney disease
This medication is used with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It also assists in reducing the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. In patients with chronic kidney disease, this drug is used to lower the risk of kidney function decline and kidney-related mortality. Thus, this medication is extensively used to improve the health of patients with diabetes, heart failure, and kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure or chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients who have had allergic reactions to the active ingredients or excipients, in patients with type 1 diabetes, those with diabetic ketoacidosis, and patients undergoing dialysis. It should be used with caution in patients with decreased fluid volume or renal impairment, and fluid status and renal function should be carefully assessed before administration. After administration, symptoms of hypotension and renal function should be continuously monitored. The blood sugar control effect of this medication varies with renal function, and caution is necessary as its effectiveness may be reduced in patients with moderate to severe renal impairment. The most common side effect noted in clinical trials and post-marketing studies was genital infections, which may occur more frequently in women or in patients with a history of infections. Hypoglycemia may occur when used in conjunction with insulin or sulfonylureas, so insulin or sulfonylurea doses should be adjusted to reduce the risk of hypoglycemia when co-administered with this medication. Dehydration or hypotension due to decreased fluid volume may occur, especially in elderly patients or those taking diuretics, so fluid status must be closely monitored. Serious metabolic complications such as diabetic ketoacidosis may rarely occur in patients taking this medication, so immediate consultation with healthcare providers and appropriate testing is required if symptoms or signs appear. There is an increased risk of urinary tract infections and pyelonephritis, so prompt treatment is necessary if infection symptoms present. Rare but serious cases of skin infections such as perineal necrosis have been reported; if pain, swelling, or redness occurs around the perineum, immediate medical attention is required. Women who are pregnant or planning to become pregnant should avoid taking this medication, and it is also advised against for breastfeeding women. Safety and efficacy in children and adolescents have not been established, thus it is not used in this age group. In cases of overdose, there is no specific antidote, and symptomatic treatment should be provided based on symptoms. This medication does not significantly affect driving or operating machinery, but caution is advised due to the risk of hypoglycemia when taken with insulin or sulfonylureas. Finally, this medication should be stored out of reach of children and kept in the original container to maintain its quality.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, initial treatment renal creatinine clearance reduction, dyslipidemia, initial treatment serum creatinine elevation, elevated serum urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, paraesthesia, hypoesthesia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, polyuria, headache, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like symptoms, vaginal discharge, irregular menstruation, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container to prevent air and moisture from penetrating. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Yellow, biconvex, diamond-shaped film-coated tablet
28 tablets/box [(7 tablets/Alu-Alu x 4)], 30 tablets/bottle, 28 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.